Although [18F]FDG PET/CT has some limitations for low proliferation, low-grade, and/or well-differentiated luminal tumors, [18F]FDG PET/CT imaging is useful for initial BC staging, regardless of tumor phenotype (ER+/HER2-, triple negative, or HER2+) and tumor grade. The gene discussed is ERBB2; the disease is breast cancer.